James Shannon
Chairman chez MANNKIND CORPORATION
Fortune : 251 717 $ au 31/03/2024
Provenance du réseau au premier degré de James Shannon
Entité | Type d'entité | Industrie | |
---|---|---|---|
The Royal College of Physicians
117
| College/University | Other Consumer Services | 117 |
50
| Public Company | Pharmaceuticals: Major | 50 |
Public Company | Pharmaceuticals: Major | 35 | |
Subsidiary | Pharmaceuticals: Major | 33 | |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland.
27
| Subsidiary | Pharmaceuticals: Major | 27 |
Public Company | Pharmaceuticals: Major | 27 | |
Subsidiary | Pharmaceuticals: Major | 15 | |
Impatients NV
Impatients NV Miscellaneous Commercial ServicesCommercial Services Impatients N.V. operates an online platform for drug innovations. It provides physicians and patients that are excluded from clinical trials access to drugs in development via early access programs. The company was founded by Ronald Brus, SJaak Vink, Govert J. Schouten, Witt Jan, Erdem Yavuz, and René Beukema in 2012 and is headquartered in Amsterdam, the United Kingdom.
14
| Holding Company | Miscellaneous Commercial Services | 14 |
Sterling Winthrop, Inc.
Sterling Winthrop, Inc. Electronics/AppliancesConsumer Durables Part of GSK Plc, Sterling Winthrop, Inc. is a private company that specializes in cameras and duplicating machines. The company is based in Rochester, NY. Sterling Winthrop was acquired by GSK Plc from Eastman Kodak Co. on November 03, 1994 for $2,930 million.
10
| Subsidiary | Electronics/Appliances | 10 |
Leyden Laboratories B.V.
Leyden Laboratories B.V. Miscellaneous Commercial ServicesCommercial Services Leyden Laboratories B.V. is a biotechnology company based in Amsterdam, Netherlands. Leyden Labs aims to protect humanity from known and future viruses by targeting commonalities of viral families. The Dutch company has developed a portfolio of accessible intranasal product candidates that may provide people with the freedom to immediately protect themselves from and prevent the spread of many strains of respiratory viruses, including ones in the influenza and coronavirus families. The company's energetic team of world-renowned biotechnology veterans and fresh talent is dedicated to thinking differently to free humanity from the burden of respiratory viruses. Leyden Labs is backed with $200m by blue-chip investors Casdin Capital, GV (formerly Google Ventures), F-Prime Capital, Byers Capital/Brook Byers, SoftBank Investment Advisers, Invus, and Bluebird Ventures. The company was founded in June 2020 by Koenraad Wiedhaup, Jaap Goudsmit, Domenico Valerio, and Ronald H. P. Brus, with Koenraad Wiedhaup serving as the CEO since incorporation.
9
| Holding Company | Miscellaneous Commercial Services | 9 |
Crucell NV
Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands.
7
| Extinct | Pharmaceuticals: Major | 7 |
Subsidiary | Pharmaceuticals: Major | 5 | |
Cerimon Pharmaceuticals, Inc.
Cerimon Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Cerimon Pharmaceuticals, Inc. developed and distributed biopharmaceutical products. It developed Simulect, a monoclonal antibody for the treatment of moderate-to-severe and steroid-refractory ulcerative colitis; diclofenac sodium, a non-steroidal anti-inflammatory drug that are used to treat various pains, included pain due to musculoskeletal injuries and lower back pain; and topical diclofenac sodium patch products. The company was founded by Paul J. Sekhri, Ansbert Gadicke, and Luke Evnin in November 2004 and was headquartered in South San Francisco, CA.
4
| Extinct | Medical Specialties | 4 |
Immodulon Therapeutics Ltd.
Immodulon Therapeutics Ltd. BiotechnologyHealth Technology Part of Lifexx SA, Immodulon Therapeutics Ltd. is a late-stage clinical biotechnology company based in Uxbridge, UK. Immodulon is developing a highly differentiated cancer immunotherapy approach that primes the patient’s own innate immune system with the aim to significantly enhance the efficacy of a broad range of anti-cancer therapies, including chemotherapy and checkpoint inhibitors. The British company is developing imm-101, a heat-killed mycobacterium obuense, as a broad-spectrum immunomodulatory agent with the potential to treat a range of difficult-to-treat tumors including those considered to be immunologically “ cold, ” such as pancreatic cancer. Immodulon's imm-101 based immunotherapy complements other cancer therapies, including immune checkpoint inhibitors and chemotherapy. The private company is focused on developing safe and effective immunotherapy treatments. The company was founded in 2007 by Charles Akle, John L. Stanford. Gertjan Bartlema has been the CEO of the company since 2022.
2
| Subsidiary | Biotechnology | 2 |
Kyowa Kirin Ltd.
Kyowa Kirin Ltd. Pharmaceuticals: MajorHealth Technology Founded in 1998, Kyowa Kirin Ltd. is a British pharmaceutical company that develops, manufactures, and distributes pharmaceutical products. Part of Kirin Holdings Co., Ltd., the private company is based in London, UK.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à James Shannon via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
ANTARES PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
HALOZYME THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Chief Executive Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
GALAPAGOS NV | Biotechnology | Director/Board Member President | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
SHIRE | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
AURA BIOSCIENCES, INC. | Biotechnology | Director/Board Member Chief Operating Officer | |
University of Pennsylvania | College/University | Graduate Degree Masters Business Admin | |
University of Oxford | College/University | Undergraduate Degree Corporate Officer/Principal Graduate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
Imperial College London | College/University | Doctorate Degree Undergraduate Degree Graduate Degree Masters Business Admin | |
Parke-Davis & Co. Ltd.
Parke-Davis & Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Parke-Davis & Co. Ltd. is a British pharmaceutical company. The private company is based in St. Helier, UK. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
University of Glasgow | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
Galapagos Biotech Ltd.
Galapagos Biotech Ltd. BiotechnologyHealth Technology Galapagos Biotech Ltd. operates as a drug discovery company which provides discovery technologies and services. Its technologies include Chemogenomics and Silico. The company was founded by Kenneth Leslie Powell and Janet Maureen Thornton in July 8, 1997 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Chairman Director/Board Member | |
University of Cambridge | College/University | Doctorate Degree Graduate Degree Undergraduate Degree | |
Pharming NV
Pharming NV Miscellaneous Commercial ServicesCommercial Services Part of Sanofi, Pharming NV is a Belgian company that develops therapeutic products for the treatment of a range of medical indications. The private company is based in Geel, Belgium. Pharming was acquired by Genzyme Corp., a subsidiary of Sanofi from Pharming Group NV on October 30, 2001. | Miscellaneous Commercial Services | Chairman Corporate Officer/Principal | |
University of Leeds | College/University | Doctorate Degree Doctorate Degree | |
Cancer Research Institute
Cancer Research Institute Medical/Nursing ServicesHealth Services Cancer Research Institute provides cancer immunotherapy services. The private company is based in New York, NY and has subsidiaries in the United States. The company was founded in 1953. Jill O'Donnell-Tormey has been the CEO of the company since 1987. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
University of California, Los Angeles | College/University | Graduate Degree Corporate Officer/Principal Graduate Degree | |
Massachusetts Institute of Technology | College/University | Undergraduate Degree Director/Board Member | |
The California State University | College/University | Undergraduate Degree Undergraduate Degree | |
University of Hong Kong | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree | |
University of London | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree Doctorate Degree | |
The University of Edinburgh | College/University | Undergraduate Degree Director/Board Member Undergraduate Degree Doctorate Degree | |
INSEAD | College/University | Masters Business Admin Masters Business Admin | |
University of Amsterdam | College/University | Graduate Degree Graduate Degree Corporate Officer/Principal | |
Financial Executives International
Financial Executives International Miscellaneous Commercial ServicesCommercial Services Financial Executives International enhances member professional development through peer networking, career planning services, conferences, publications and special reports, and research. Its members include Chief Financial Officers, Vice Presidents of Finance, Treasurers, and Controllers. The company was founded in December 1931 and is headquartered in Morristown, NJ. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
University College London | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Affectis Pharmaceuticals AG
Affectis Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Affectis Pharmaceuticals AG discovers and develops drugs for the treatment of neurodegenerative and neuroinflammatory diseases. Its products in pipeline include AFC-5128, P2X7 Compounds, AFC-5278 and AFC-08. The company was founded in January 2004 by Florian Holsboer, Wolfgang Wurst and Herbert Stadler and is headquartered in Dortmund, Germany. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Janssen Vaccines & Prevention BV
Janssen Vaccines & Prevention BV Pharmaceuticals: MajorHealth Technology Janssen Vaccines & Prevention BV manufactures and supplies biopharmaceutical products. The company was founded in 2000 and is headquartered in Leiden, the Netherlands. | Pharmaceuticals: Major | Chief Executive Officer General Counsel | |
University of Leiden | College/University | Corporate Officer/Principal Graduate Degree | |
Faculty of Pharmaceutical Medicine | Corporate Officer/Principal Corporate Officer/Principal | ||
Healthcare Royalty Management LLC
Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty Management LLC (Healthcare Royalty) is a private equity subsidiary of Cowen, Inc. founded in 2007 by Gregory Brown. The firm is headquartered in Stamford, Connecticut. | Investment Managers | Corporate Officer/Principal Consultant / Advisor Corporate Officer/Principal | |
American College of Cardiology Foundation
American College of Cardiology Foundation Medical/Nursing ServicesHealth Services American College of Cardiology Foundation provides cardiovascular education services. Its services include cardiac surgery, chronic angine, diabetes, geriatric cardiology and heart failure and cardiomyopathies. The company was founded by Franz Groedel, Robert P. Glover and Bruno Kisc in 1949 and is headquartered in Washington, DC. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Aescap Venture Management BV
Aescap Venture Management BV Investment ManagersFinance Aescap Venture Management BV is an independent venture capital investment firm based in Amsterdam. Aescap was founded in 2005 by Michiel de Haan and Dinko Valerio. Inspired by the name of the Greek god of healthcare, Aesculapiu, the firm's name is an acronym for 'Accelerating European Science Companies and Products.' The firm focuses on developing growth in European firms in the biomedical sector. | Investment Managers | Founder Private Equity Investor | |
CLOVIS ONCOLOGY, INC. | Pharmaceuticals: Major | Founder Chief Tech/Sci/R&D Officer | |
American Heart Association (New York)
American Heart Association (New York) Miscellaneous Commercial ServicesCommercial Services Part of American Heart Association, Inc., American Heart Association (New York) provides public health educational services. The private company is based in New York, NY. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
The Royal College of Paediatrics & Child Health | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
The Wharton School of the University of Pennsylvania | College/University | Doctorate Degree Masters Business Admin | |
UCL Medical School | College/University | Doctorate Degree Doctorate Degree | |
Amylon Therapeutics BV
Amylon Therapeutics BV Pharmaceuticals: MajorHealth Technology Amylon Therapeutics BV is a biopharmaceutical company, which engages in the research and development of therapies for the central nervous system. It specializes in ribonucleic acid modulation technology to target rare genetic disorders. The company was founded by Thomas de Vlaam and is headquartered in Leiden, the Netherlands. | Pharmaceuticals: Major | Director/Board Member Founder | |
X4 PHARMACEUTICALS, INC. | Biotechnology | Founder Director/Board Member | |
Royal Free Hospital Medical School | College/University | Doctorate Degree Doctorate Degree | |
Charing Cross Hospital Medical School | College/University | Doctorate Degree Graduate Degree |
Statistiques
Internationale
Etats-Unis | 25 |
Royaume-Uni | 16 |
Pays-Bas | 6 |
Belgique | 3 |
Irlande | 2 |
Sectorielle
Consumer Services | 21 |
Health Technology | 19 |
Commercial Services | 6 |
Finance | 4 |
Health Services | 3 |
Opérationnelle
Director/Board Member | 459 |
Corporate Officer/Principal | 306 |
Independent Dir/Board Member | 124 |
Chairman | 105 |
Chief Tech/Sci/R&D Officer | 91 |
Relations les plus connectées
Insiders | |
---|---|
Paul Sekhri | 62 |
Chrisantha Nicholas Nonis | 47 |
Henri A. Termeer | 42 |
Frank Armstrong | 41 |
Martin Edwards | 38 |
Sabrina Kay | 32 |
Alfred Mann | 31 |
Michael Friedman | 30 |
Kent Kresa | 27 |
William Burns | 27 |
Yiu Nam Lau | 26 |
Philip Hampton | 24 |
Alison Lawton | 24 |
Kei Siong Khoo | 23 |
Warren Cooper | 21 |
- Bourse
- Insiders
- James Shannon
- Connexions Sociétés